ACT Network

The Accrual to Clinical Trials (ACT) Network is a real-time platform allowing researchers to explore and validate feasibility for clinical studies across the NCATS Clinical and Translational Science Award (CTSA) consortium, from their desktops. ACT helps researchers design and complete clinical studies, and is secure, HIPAA-compliant and IRB-approved. Learn more

  • Banner image for the ACT Network COVID-19 webinar May 5, 2020
    University Of Colorado Denver

    The Accrual to Clinical Trials (ACT) Network is an NIH/NCATS funded clinical informatics platform allowing users to query de-identified EHR data across the CTSA consortium. Using proven ACT technology and existing governance/data use agreements, the network has quickly mobilized to create a scalable COVID-19 research platform. This effort has focused on COVID-19 extensions to the ACT query